Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-26 @ 10:17 PM
NCT ID:
NCT00008112
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically or cytologically confirmed stage IIB-IVA carcinoma of the cervix
* Adenocarcinoma
* Squamous cell carcinoma
* Mixed cell histology
* No small cell anaplastic histology
* No para-aortic lymph node involvement
* No indication for para-aortic radiotherapy
* No distant metastases
* No CNS disease
PATIENT CHARACTERISTICS:
Age:
* 18 and over
Performance status:
* WHO 0-2
Life expectancy:
* More than 3 months
Hematopoietic:
* WBC at least 3,000/mm\^3
* Absolute neutrophil count at least 1,500/mm\^3
* Platelet count at least 100,000/mm\^3
* Hemoglobin at least 7.0 mmol/L (approximately 11 g/dL)
* Epoetin alfa and/or transfusion allowed
Hepatic:
* Not specified
Renal:
* Glomerular filtration rate at least 60 mL/min
Cardiovascular:
* No myocardial infarction within the past 6 months
* No unstable angina
* No congestive heart failure with expected inability to tolerate fluid load
* No cerebrovascular accident within the past 6 months
Other:
* No pacemaker and/or metal implants
* No active uncontrolled infection
* No compromised immune status
* No psychosis
* No other prior malignancy except nonmelanoma skin cancer
* No mental or other physical inability that would preclude study
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* No prior chemotherapy
Endocrine therapy:
* Not specified
Radiotherapy:
* See Disease Characteristics
* No prior radiotherapy
Surgery:
* No prior surgery
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00008112
Study Brief:
Protocol Section:
NCT00008112